Lale Kostakoglu

5PUBLICATIONS
46CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Semi- and unsupervised learningCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 09, 2026
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma.

Catherine Diefenbach, Opeyemi Jegede, Victoria Wang

|Jun 06, 2024
Automated Lugano Metabolic Response Assessment in 18F-Fluorodeoxyglucose-Avid Non-Hodgkin Lymphoma With Deep Learning on 18F-Fluorodeoxyglucose-Positron Emission Tomography.

Skander Jemaa, Souhila Ounadjela, Xiaoyong Wang

|Oct 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance).

Ann S LaCasce, Travis Dockter, Amy S Ruppert

|Jul 11, 2022
PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design.

Kristine Broglio, Lale Kostakoglu, Carol Ward

|Feb 08, 2021
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412.

Grzegorz S Nowakowski, Fangxin Hong, David W Scott

Pageof 1

Frequent Collaborators

2 joint publications

David W Scott

2 joint publications

Jonathon B Cohen

2 joint publications

Jennifer Effie Amengual

2 joint publications

Nancy L Bartlett